Net Income (Loss) Per Common Share - Basic and Diluted

9 Months Ended

Sep. 30, 2019

Earnings Per Share [Abstract]

Net Income (Loss) Per Common Share - Basic and Diluted

(3)       Net Income (Loss) Per Common Share - Basic and Diluted

For the nine months ended September 30, 2019, the Company had 23,605,000 stock options outstanding, 20,090,000 warrants outstanding, 4,213 outstanding shares of Series C redeemable convertible preferred stock (Series C Preferred Stock), and 850 outstanding shares of Series B redeemable convertible preferred stock (Series B Preferred Stock), each of which were not included in the computation of diluted income (loss) per common share because they would be anti-dilutive. For the three months ended September 30, 2019, the Company had 13,805,000 stock options outstanding, 20,090,000 warrants outstanding, 4,213 outstanding shares of Series C redeemable convertible preferred stock (Series C Preferred Stock), and 850 outstanding shares of Series B redeemable convertible preferred stock (Series B Preferred Stock), each of which were not included in the computation of diluted income (loss) per common share because they would be anti-dilutive.

The table below shows the calculation of diluted shares:

	3 Months Ended				9 Months Ended
	September 30, 2019		September 30, 2018		September 30, 2019		September 30, 2018
Weighted average common shares outstanding - basic		419,800,218		412,934,573		417,645,817		410,529,878
Effect of dilutive shares
Stock Options		9,800,000		—		—		—
Warrants		—		—		—		—
Series B redeemable convertible preferred stock		—		—		—		—
Series C redeemable convertible preferred stock		—		—		—		—
Weighted average common shares outstanding - diluted		429,600,218		412,934,573		417,645,817		410,529,878

For the nine months ended September 30, 2018, the Company had 27,805,000 stock options outstanding, 45,090,000 warrants outstanding, 4,213 outstanding shares of Series C Preferred Stock, and 850 outstanding shares of Series B Preferred Stock, each of which were not included in the computation of diluted income per common share because they would be anti-dilutive.

The table below summarizes common stock equivalents outstanding at September 30, 2019 and 2018:

	September 30,
	2019		2018
Stock options		23,605,000		27,805,000
Warrants		20,090,000		45,090,000
850 Shares of Series B redeemable convertible preferred stock		425,000		425,000
4,213 Shares of Series C redeemable convertible preferred stock		42,130,000		42,130,000
		86,250,000		115,450,000